Cargando…
Response to growth hormone in patients with RNPC3 mutations
After 6 years of Growth Hormone (GH) therapy, three patients with a defect in minor spliceosome mRNA processing leading to an incompletely understood GH deficit present with excellent auxological response and improvement in the bone mineral density and trabecular bone structure. [Image: see text]
Autores principales: | Martos‐Moreno, Gabriel Á, Travieso‐Suárez, Lourdes, Pozo‐Román, Jesús, Muñoz‐Calvo, María T, Chowen, Julie A, Frilander, Mikko J, Pérez‐Jurado, Luis A, Hawkins, Federico G, Argente, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034130/ https://www.ncbi.nlm.nih.gov/pubmed/29866761 http://dx.doi.org/10.15252/emmm.201809143 |
Ejemplares similares
-
Defective minor spliceosome mRNA processing results in isolated familial growth hormone deficiency
por: Argente, Jesús, et al.
Publicado: (2014) -
Pathogenic Variants in RNPC3 are Associated with Hypopituitarism and Primary Ovarian Insufficiency
por: Akin, Leyla, et al.
Publicado: (2022) -
Ethnicity Strongly Influences Body Fat Distribution Determining Serum Adipokine Profile and Metabolic Derangement in Childhood Obesity
por: Martos-Moreno, Gabriel Á., et al.
Publicado: (2020) -
Neuroprotective Actions of Ghrelin and Growth Hormone Secretagogues
por: Frago, Laura M., et al.
Publicado: (2011) -
Heterozygous rare genetic variants in non-syndromic early-onset obesity
por: Serra-Juhé, Clara, et al.
Publicado: (2019)